Literature DB >> 24486052

T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.

Florian Rieder1, Ilche Nonevski2, Jie Ma3, Zhufeng Ouyang2, Gail West4, Cheryl Protheroe5, Giovanni DePetris6, Anja Schirbel4, James Lapinski7, John Goldblum7, Tracey Bonfield8, Rocio Lopez9, Karen Harnett3, James Lee5, Ikuo Hirano10, Gary Falk2, Piero Biancani3, Claudio Fiocchi11.   

Abstract

BACKGROUND & AIMS: Patients with eosinophilic esophagitis (EoE) often become dysphagic from the combination of organ fibrosis and motor abnormalities. We investigated mechanisms of dysphagia, assessing the response of human esophageal fibroblasts (HEFs), human esophageal muscle cells (HEMCs), and esophageal muscle strips to eosinophil-derived products.
METHODS: Biopsy specimens were collected via endoscopy from the upper, middle, and lower thirds of the esophagus of 18 patients with EoE and 21 individuals undergoing endoscopy for other reasons (controls). Primary cultures of esophageal fibroblasts and muscle cells were derived from 12 freshly resected human esophagectomy specimens. Eosinophil distribution was investigated by histologic analyses of full-thickness esophageal tissue. Active secretion of EoE-related mediators was assessed from medium underlying mucosal biopsy cultures. We quantified production of fibronectin and collagen I by HEF and HEMC in response to eosinophil products. We also measured the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of human eosinophils to, HEFs and HEMCs. Eosinophil products were tested in an esophageal muscle contraction assay.
RESULTS: Activated eosinophils were present in all esophageal layers. Significantly higher concentrations of eosinophil-related mediators were secreted spontaneously in mucosal biopsy specimens from patients with EoE than controls. Exposure of HEFs and HEMCs to increasing concentrations of eosinophil products or co-culture with eosinophils caused HEFs and HEMCs to increase secretion of fibronectin and collagen I; this was inhibited by blocking transforming growth factor β1 and p38 mitogen-activated protein kinase signaling. Eosinophil binding to HEFs and HEMCs increased after incubation of mesenchymal cells with eosinophil-derived products, and decreased after blockade of transforming growth factor β1 and p38 mitogen-activated protein kinase blockade. Eosinophil products reduced electrical field-induced contraction of esophageal muscle strips, but not acetylcholine-induced contraction.
CONCLUSIONS: In an analysis of tissues samples from patients with EoE, we linked the presence and activation state of eosinophils in EoE with altered fibrogenesis and motility of esophageal fibroblasts and muscle cells. This process might contribute to the development of dysphagia.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immune Regulation; Primary Human Cells; Swallowing; Transmural Disease

Mesh:

Substances:

Year:  2014        PMID: 24486052      PMCID: PMC3992171          DOI: 10.1053/j.gastro.2014.01.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Tissue remodeling in patients with eosinophilic esophagitis: what lies beneath the surface?

Authors:  Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-11       Impact factor: 10.793

2.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

3.  Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy.

Authors:  Joohee Lee; James Huprich; Christine Kujath; Karthik Ravi; Felicity Enders; Thomas C Smyrk; David A Katzka; Nicholas J Talley; Jeffrey A Alexander
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-03       Impact factor: 11.382

4.  Manometric features of eosinophilic esophagitis in esophageal pressure topography.

Authors:  S Roman; I Hirano; M A Kwiatek; N Gonsalves; J Chen; P J Kahrilas; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2010-11-23       Impact factor: 3.598

5.  Esophageal functional impairments in experimental eosinophilic esophagitis.

Authors:  Parm Mavi; Priya Rajavelu; Madhavi Rayapudi; Richard J Paul; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-23       Impact factor: 4.052

6.  Transmural eosinophilic infiltration and fibrosis in a patient with non-traumatic Boerhaave's syndrome due to eosinophilic esophagitis.

Authors:  Maria Fontillón; Alfredo J Lucendo
Journal:  Am J Gastroenterol       Date:  2012-11       Impact factor: 10.864

7.  Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Jonathan M Spergel; Marc E Rothenberg; Margaret H Collins; Glenn T Furuta; Jonathan E Markowitz; George Fuchs; Molly A O'Gorman; Juan Pablo Abonia; James Young; Timothy Henkel; H Jeffrey Wilkins; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

8.  Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: Implications for endoscopic biopsy.

Authors:  Hedieh Saffari; Kathryn A Peterson; John C Fang; Carolin Teman; Gerald J Gleich; Leonard F Pease
Journal:  J Allergy Clin Immunol       Date:  2012-04-12       Impact factor: 10.793

9.  Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.

Authors:  Anil Mishra; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

10.  ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

Authors:  Evan S Dellon; Nirmala Gonsalves; Ikuo Hirano; Glenn T Furuta; Chris A Liacouras; David A Katzka
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

View more
  54 in total

1.  Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.

Authors:  Amanda B Muir; Kara Dods; Steven J Henry; Alain J Benitez; Dale Lee; Kelly A Whelan; Maureen DeMarshall; Daniel A Hammer; Gary Falk; Rebecca G Wells; Jonathan Spergel; Hiroshi Nakagawa; Mei-Lun Wang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-08       Impact factor: 2.839

Review 2.  Role of Endoscopy in Diagnosis and Management of Pediatric Eosinophilic Esophagitis.

Authors:  Amanda B Muir; Jamie Merves; Chris A Liacouras
Journal:  Gastrointest Endosc Clin N Am       Date:  2016-01

Review 3.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 4.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 5.  Eosinophilic esophagitis: pathophysiology and its clinical implications.

Authors:  Eisuke Inage; Glenn T Furuta; Calies Menard-Katcher; Joanne C Masterson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-13       Impact factor: 4.052

6.  Contribution of Esophagram to the Evaluation of Complicated Pediatric Eosinophilic Esophagitis.

Authors:  Calies Menard-Katcher; Mathew P Swerdlow; Pooja Mehta; Glenn T Furuta; Laura Z Fenton
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-11       Impact factor: 2.839

7.  The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video).

Authors:  Evan S Dellon; Jessica H Gebhart; Leana L Higgins; Kelly E Hathorn; John T Woosley; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-07-02       Impact factor: 9.427

8.  Resolution of Refractory Eosinophilic Esophagitis with the Leukocyte-Trafficking Inhibitor Natalizumab.

Authors:  Ian L P Beales
Journal:  Dig Dis Sci       Date:  2019-06-12       Impact factor: 3.199

Review 9.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

Review 10.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.